Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

US
FDA Approves Unknown Drug — US ANTIBIOTICS

FDA has granted approval to US Antibiotics for the industrial manufacturing and distribution of pharmaceutical products, a move expected to expand the...

PAI
FDA Approves Unknown Drug — PAI HOLDINGS

PAI Holdings announced today that the FDA has approved the 1996-era ANDA referencing NDA058389, a development likely aimed at enhancing product availa...

USAntibiotics,
FDA Approves AMOXICILLIN AND CLAVULANATE POTASSIUM — USAntibiotics, LLC

USAntibiotics, LLC received FDA approval for Amoxicillin and Clavulanate Potassium, a significant development for the generic market that shortens the...

TerSera
FDA Approves ZOLADEX — TerSera Therapeutics LLC

# FDA Approves ZOLADEX (Goserelin Acetate) for TerSera Therapeutics TerSera Therapeutics LLC has received FDA approval for ZOLADEX (goserelin acetate...

TERSERA
FDA Approves Unknown Drug — TERSERA

# FDA Approves TERSERA Drug Application TERSERA has received FDA approval for a new drug application (NDA020515), marking a significant entry into th...

Kenvue
FDA Approves ZYRTEC HIVES — Kenvue Brands LLC

Kenvue Brands LLC has announced that the FDA has approved the antihistamine Cetirizine Hydrochloride (ZYRTEC HIVES) via BLA NDA019835. This approval s...

Padagis
FDA Approves CLINDAMYCIN PHOSPHATE — Padagis Israel Pharmaceuticals Ltd

Padagis Israel Pharmaceuticals Ltd reported the approval of its 505(b)(2) application (and label extension) for topical clindamycin phosphate to marke...

Baxter
FDA Approves DOXORUBICIN HYDROCHLORIDE LIPOSOME — Baxter Healthcare Company

# FDA Approves Baxter Healthcare's Liposomal Doxorubicin Formulation Baxter Healthcare Company received FDA approval for its liposomal doxorubicin hy...

Pfizer
FDA Approves ZITHROMAX — Pfizer Laboratories Div Pfizer Inc

Pfizer secured FDA approval for the generic formulation of its blockbuster antibiotic Zithromax, a move that is expected to drive immediate market com...

Hospira,
FDA Approves LIDOCAINE HYDROCHLORIDE — Hospira, Inc.

# FDA Approves Hospira's Lidocaine Hydrochloride for Epidural Use Hospira, Inc. received FDA approval for its lidocaine hydrochloride epidural formul...

Kenvue
FDA Approves CHILDRENS MOTRIN — Kenvue Brands LLC

Kenvue Brands LLC noted today that the U.S. Food and Drug Administration recognizes Children’s Motrin (ibuprofen oral solution) as stable for up to 70...

Genentech,
FDA Approves CELLCEPT — Genentech, Inc.

The FDA has re-approved CELLCEPT (mycophenolate mofetil) following the transfer of the NDA to global markets, ensuring Genentech maintains continued e...

Hikma
FDA Approves ACETAZOLAMIDE — Hikma Pharmaceuticals USA Inc.

Hikma Pharmaceuticals USA Inc. secured FDA approval for Intravenous Acetazolamide Sodium in 1995, expanding its generic portfolio into the IV segment ...

Actavis
FDA Approves GLIPIZIDE — Actavis Pharma, Inc.

Actavis Pharma, Inc. received FDA approval for its generic glipizide oral tablet, positioning the company to enter the competitive oral anti-diabetic ...

GlaxoSmithKline
FDA Approves MEPRON — GlaxoSmithKline LLC

GlaxoSmithKline announced the FDA approval of oral Atovaquone (Mepron) for the treatment of Pneumocystis pneumonia, a strategic addition expected to b...

HIKMA
FDA Approves Unknown Drug — HIKMA

# FDA Approves Hikma Generic Drug Application Hikma Pharmaceuticals has received FDA approval for an abbreviated new drug application (ANDA 074060), ...

SANDOZ
FDA Approves Unknown Drug — SANDOZ

Sandoz’s pivotal 1994 approval of this key pharmaceutical product marked a significant milestone for the company's portfolio, laying the groundwork fo...

Ferring
FDA Approves STIMATE — Ferring Pharmaceuticals Inc.

Ferring Pharmaceuticals Inc. confirmed the FDA approval of the generic version of STIMATE (desmopressin acetate), a nasal hormone replacement therapy ...

Sandoz
FDA Approves APRACLONIDINE — Sandoz Inc

# FDA Approves Sandoz's Apraclonidine for Ophthalmic Use Sandoz Inc. received FDA approval for apraclonidine hydrochloride, an ophthalmic treatment t...

TAKEDA
FDA Approves Unknown Drug — TAKEDA PHARMS USA

Takeda Pharmaceuticals USA announced today that it has received FDA approval for the reclassification of its NDA020049, signaling a pivotal shift in t...